300194 福安药业
交易中 02-24 13:14:03
资讯
新帖
简况
福安药业最新公告：子公司药品拟中选国家集采药品接续采购
证券之星 · 02-12
福安药业最新公告：子公司药品拟中选国家集采药品接续采购
福安药业：截止2月10日，公司股东户数为38647户
证券之星 · 02-12
福安药业：截止2月10日，公司股东户数为38647户
股市必读：福安药业（300194）2月4日董秘有最新回复
证券之星 · 02-05
股市必读：福安药业（300194）2月4日董秘有最新回复
福安药业：截止1月30日，公司股东户数为39053户
证券之星 · 02-03
福安药业：截止1月30日，公司股东户数为39053户
股市必读：福安药业（300194）预计2025年全年扣非后净利润盈利5200万元至7800万元
证券之星 · 02-02
股市必读：福安药业（300194）预计2025年全年扣非后净利润盈利5200万元至7800万元
福安药业：预计2025年全年扣非后净利润盈利5200万元至7800万元
证券之星 · 01-30
福安药业：预计2025年全年扣非后净利润盈利5200万元至7800万元
福安药业最新公告：子公司收到头孢托仑匹酯片药品注册证书
证券之星 · 01-30
福安药业最新公告：子公司收到头孢托仑匹酯片药品注册证书
福安药业（300194）披露子公司收到盐酸尼卡地平注射液药品注册证书公告，1月26日股价上涨2.16%
证券之星 · 01-26
福安药业（300194）披露子公司收到盐酸尼卡地平注射液药品注册证书公告，1月26日股价上涨2.16%
福安药业(300194)1月9日股东户数3.88万户，较上期减少0.52%
证券之星 · 01-13
福安药业(300194)1月9日股东户数3.88万户，较上期减少0.52%
股市必读：福安药业(300194)股东户数3.9万户，较上期减少8.31%
证券之星 · 01-12
股市必读：福安药业(300194)股东户数3.9万户，较上期减少8.31%
福安药业：截止12月31日股东户数为39047户
证券之星 · 01-09
福安药业：截止12月31日股东户数为39047户
福安药业（300194）披露变更2025年度审计机构公告，1月6日股价上涨0.22%
证券之星 · 01-06
福安药业（300194）披露变更2025年度审计机构公告，1月6日股价上涨0.22%
福安药业：公司属于深股通标的证券
证券之星 · 2025-12-29
福安药业：公司属于深股通标的证券
福安药业(300194.SZ)子公司收到盐酸曲唑酮片药品注册证书
智通财经 · 2025-12-22
福安药业(300194.SZ)子公司收到盐酸曲唑酮片药品注册证书
福安药业：截止12月19日股东户数为42588户
证券之星 · 2025-12-22
福安药业：截止12月19日股东户数为42588户
福安药业（300194）披露召开2026年第一次临时股东会通知，12月19日股价上涨0.86%
证券之星 · 2025-12-19
福安药业（300194）披露召开2026年第一次临时股东会通知，12月19日股价上涨0.86%
福安药业：截止12月10日股东户数为38855户
证券之星 · 2025-12-16
福安药业：截止12月10日股东户数为38855户
福安药业（300194）披露子公司收到药品注册证书，12月10日股价上涨1.56%
证券之星 · 2025-12-10
福安药业（300194）披露子公司收到药品注册证书，12月10日股价上涨1.56%
福安药业(300194.SZ)子公司产品纳入国家医保药品目录
智通财经 · 2025-12-08
福安药业(300194.SZ)子公司产品纳入国家医保药品目录
福安药业：多维度提升管理效能
证券之星 · 2025-12-02
福安药业：多维度提升管理效能
加载更多
公司概况
公司名称：
福安药业(集团)股份有限公司
所属行业：
医药制造业
上市日期：
2011-03-22
主营业务：
福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是庆大霉素、头孢唑肟钠、头孢美唑钠、拉氧头孢钠、头孢他啶、枸橼酸托瑞米芬片（制剂）、盐酸昂丹司琼（原料药、制剂）、盐酸格拉司琼（原料药、制剂）、多索茶碱（原料药、制剂）、尼麦角林胶囊、舒林酸片、谷胱甘肽。
发行价格：
41.88
{"stockData":{"symbol":"300194","market":"SZ","secType":"STK","nameCN":"福安药业","latestPrice":4.42,"timestamp":1771910043000,"preClose":4.36,"halted":0,"volume":6902019,"delay":0,"changeRate":0.0138,"floatShares":968000000,"shares":1190000000,"eps":0.1215,"marketStatus":"交易中","change":0.06,"latestTime":"02-24 13:14:03","open":4.38,"high":4.42,"low":4.37,"amount":30359600,"amplitude":0.0115,"askPrice":4.42,"askSize":6541,"bidPrice":4.41,"bidSize":2301,"shortable":0,"etf":0,"ttmEps":0.1215,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771916400000},"marketStatusCode":2,"adr":0,"adjPreClose":4.36,"symbolType":"stock","openAndCloseTimeList":[[1771896600000,1771903800000],[1771909200000,1771916400000]],"highLimit":4.8,"lowLimit":3.92,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1189712382,"isCdr":false,"pbRate":1.17,"roa":"--","peRate":36.378601,"roe":"3.73%","epsLYR":0.24,"committee":-0.11284,"marketValue":5259000000,"turnoverRate":0.0071,"status":0,"floatMarketCap":4280000000},"requestUrl":"/m/hq/s/300194","defaultTab":"news","newsList":[{"id":"2610705945","title":"福安药业最新公告：子公司药品拟中选国家集采药品接续采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2610705945","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610705945?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:12","pubTimestamp":1770887532,"startTime":"0","endTime":"0","summary":"福安药业公告称，根据国家组织集采药品协议期满品种接续采购办公室于2月10日发布的《国家组织集采药品协议期满品种接续采购拟中选结果表》显示，公司子公司共计28个药品品种拟中选本次接续采购。公司子公司本次拟中选的28个药品品种2024年度合计销售额为6.8亿元，占公司2024年度营业收入比例为28.43%；上述拟中选的产品2025年前三季度合计销售额为3.29亿元，占公司2025年前三季度营业收入比例为25.05%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200027628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300194","BK0060","BK0239","BK0132"],"gpt_icon":0},{"id":"2610917249","title":"福安药业：截止2月10日，公司股东户数为38647户","url":"https://stock-news.laohu8.com/highlight/detail?id=2610917249","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610917249?lang=zh_cn&edition=full","pubTime":"2026-02-12 15:45","pubTimestamp":1770882318,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业(300194)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好，请问截止至2026年2月10日收盘公司股东人数为多少，谢谢！福安药业回复：截止2月10日，公司股东户数为38647户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200020644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300194","BK0028","BK0060","BK0239"],"gpt_icon":0},{"id":"2609394386","title":"股市必读：福安药业（300194）2月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609394386","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609394386?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:45","pubTimestamp":1770227118,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，福安药业报收于4.48元，上涨1.13%，换手率1.63%，成交量15.76万手，成交额7004.7万元。董秘最新回复投资者： 公司股价一直严重滞后市场！2025年，受行业政策影响，公司业绩有下降，公司已在指定媒体发布2025年业绩预告。当日关注点来自交易信息汇总：2月4日主力资金净流入635.0万元，呈现主动买入态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","300194","BK0132","BK0060"],"gpt_icon":0},{"id":"2608825307","title":"福安药业：截止1月30日，公司股东户数为39053户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608825307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608825307?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:24","pubTimestamp":1770107066,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业(300194)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问1月31日公司股东人数是多少？谢谢！福安药业回复：截止1月30日，公司股东户数为39053户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300027039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194","BK0132","BK0028","BK0239","BK0060"],"gpt_icon":0},{"id":"2608895768","title":"股市必读：福安药业（300194）预计2025年全年扣非后净利润盈利5200万元至7800万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608895768","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608895768?lang=zh_cn&edition=full","pubTime":"2026-02-02 03:19","pubTimestamp":1769973550,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，福安药业报收于4.49元，下跌0.66%，换手率2.03%，成交量19.67万手，成交额8863.47万元。福安药业发布业绩预告，预计2025年全年归属净利润盈利7000万元至1亿元。福安药业预计2025年度归属于上市公司股东的净利润为7,000万元至1亿元，比上年同期下降64.26%-74.99%；扣除非经常性损益后的净利润为5,200万元至7,800万元，同比下降69.83%-79.88%。剔除商誉减值影响后，净利润预计为2.2亿元至2.5亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200001559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194"],"gpt_icon":0},{"id":"2607019608","title":"福安药业：预计2025年全年扣非后净利润盈利5200万元至7800万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607019608","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607019608?lang=zh_cn&edition=full","pubTime":"2026-01-30 18:18","pubTimestamp":1769768337,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业发布业绩预告，预计2025年全年扣非后净利润盈利5200万元至7800万元。公告中解释本次业绩变动的原因为：本报告期,公司归属于上市公司股东的净利润预计0.7亿元至1亿元,同比下降64.26%-74.99%。经初步测算,报告期总体经营业绩仍有较大幅度的下降。本报告期剔除商誉减值后,公司归属于上市公司股东的净利润预计2.2亿元至2.5亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000034199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300194"],"gpt_icon":0},{"id":"2607090784","title":"福安药业最新公告：子公司收到头孢托仑匹酯片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2607090784","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607090784?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:44","pubTimestamp":1769762693,"startTime":"0","endTime":"0","summary":"福安药业公告称，公司全资子公司福安药业集团庆余堂制药有限公司近日收到国家药品监督管理局签发的药品注册证书，药品名称为头孢托仑匹酯片，注册分类为化药4类，规格为0.1g。该药品适用于对本剂敏感菌引起的各类感染。上述药品注册证书的获得将进一步丰富子公司产品线，提升其市场竞争力。但受行业政策、市场环境变化等因素影响，上述产品的生产、销售情况以及对公司业绩的具体影响存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000028106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","BK0028","BK0060","300194"],"gpt_icon":0},{"id":"2606424675","title":"福安药业（300194）披露子公司收到盐酸尼卡地平注射液药品注册证书公告，1月26日股价上涨2.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606424675","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606424675?lang=zh_cn&edition=full","pubTime":"2026-01-26 22:32","pubTimestamp":1769437958,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘，福安药业报收于4.74元，较前一交易日上涨2.16%，最新总市值为56.39亿元。该股当日开盘4.65元，最高4.75元，最低4.63元，成交额达2.73亿元，换手率为6.0%。福安药业（集团）股份有限公司于近日披露公告称，其全资子公司福安药业集团宁波天衡制药有限公司收到国家药品监督管理局签发的盐酸尼卡地平注射液药品注册证书，规格为10ml:10mg，批准文号为国药准字H20263185，审批结论为符合药品注册要求，批准注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600036096.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0028","300194","BK0132","BK0239"],"gpt_icon":0},{"id":"2603434502","title":"福安药业(300194)1月9日股东户数3.88万户，较上期减少0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603434502","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603434502?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:38","pubTimestamp":1768297120,"startTime":"0","endTime":"0","summary":"证券之星消息，近日福安药业披露，截至2026年1月9日公司股东户数为3.88万户，较12月31日减少202.0户，减幅为0.52%。在化学制药行业个股中，福安药业股东户数高于行业平均水平，截至1月9日，化学制药行业平均股东户数为3.44万户。从股价来看，2025年12月31日至2026年1月9日，福安药业区间涨幅为1.35%，在此期间股东户数减少202.0户，减幅为0.52%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300029758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","300194","BK0132","BK0028"],"gpt_icon":0},{"id":"2602155220","title":"股市必读：福安药业(300194)股东户数3.9万户，较上期减少8.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602155220","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602155220?lang=zh_cn&edition=full","pubTime":"2026-01-12 01:47","pubTimestamp":1768153630,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，福安药业报收于4.49元，上涨0.22%，换手率2.59%，成交量25.04万手，成交额1.12亿元。股本股东变化股东户数变动近日福安药业披露，截至2025年12月31日公司股东户数为3.9万户，较12月19日减少3541.0户，减幅为8.31%。户均持股数量由上期的2.79万股增加至3.05万股，户均持股市值为13.5万元。董秘最新回复投资者： 最新股东人数董秘： 截止最新12月31日，公司股东户数为39047户，谢谢！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200000761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0239","300194","BK0132","BK0028"],"gpt_icon":0},{"id":"2602934066","title":"福安药业：截止12月31日股东户数为39047户","url":"https://stock-news.laohu8.com/highlight/detail?id=2602934066","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602934066?lang=zh_cn&edition=full","pubTime":"2026-01-09 15:15","pubTimestamp":1767942921,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业(300194)01月09日在投资者关系平台上答复投资者关心的问题。投资者提问：最新股东人数福安药业回复：截止最新12月31日，公司股东户数为39047户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900018936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0132","BK0239","BK0028","300194"],"gpt_icon":0},{"id":"2601482813","title":"福安药业（300194）披露变更2025年度审计机构公告，1月6日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601482813","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601482813?lang=zh_cn&edition=full","pubTime":"2026-01-06 22:24","pubTimestamp":1767709467,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，福安药业报收于4.51元，较前一交易日上涨0.22%，最新总市值为53.66亿元。该股当日开盘4.49元，最高4.51元，最低4.48元，成交额达8722.15万元，换手率为2.0%。公司近日发布公告称，于2026年1月6日召开2026年第一次临时股东会，审议通过《关于变更公司2025年度审计机构的议案》，同意聘请中兴华会计师事务所为公司2025年度财务报告和内部控制审计机构，审计费用共计136万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600042521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300194","BK0060","BK0132","BK0028"],"gpt_icon":0},{"id":"2595785858","title":"福安药业：公司属于深股通标的证券","url":"https://stock-news.laohu8.com/highlight/detail?id=2595785858","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595785858?lang=zh_cn&edition=full","pubTime":"2025-12-29 17:00","pubTimestamp":1766998840,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业(300194)12月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司有深股通交易吗福安药业回复：目前公司属于深股通标的证券，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900021745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300194","BK0132","BK0060","BK0239","161027"],"gpt_icon":0},{"id":"2593102134","title":"福安药业(300194.SZ)子公司收到盐酸曲唑酮片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2593102134","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593102134?lang=zh_cn&edition=full","pubTime":"2025-12-22 15:48","pubTimestamp":1766389693,"startTime":"0","endTime":"0","summary":"智通财经APP讯，福安药业(300194.SZ)发布公告，公司全资子公司福安药业集团宁波天衡制药有限公司(简称“天衡制药”)于近日收到国家药品监督管理局签发的盐酸曲唑酮片药品注册证书。盐酸曲唑酮片适用抑郁症的治疗，对伴有或不伴有焦虑的患者均有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384354.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"福安药业(300194.SZ)子公司收到盐酸曲唑酮片药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0132","BK0239","300194","BK0060"],"gpt_icon":0},{"id":"2593027101","title":"福安药业：截止12月19日股东户数为42588户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593027101","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593027101?lang=zh_cn&edition=full","pubTime":"2025-12-22 15:07","pubTimestamp":1766387235,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业(300194)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，您好！今天是12月中旬最后一个交易日，敬请发布截至今天公司的股东户数信息。谢谢！顺致周末愉快！福安药业回复：截止12月19日，公司股东户数为42588户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200012209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0060","BK0028","300194","BK0239"],"gpt_icon":0},{"id":"2592981801","title":"福安药业（300194）披露召开2026年第一次临时股东会通知，12月19日股价上涨0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592981801","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592981801?lang=zh_cn&edition=full","pubTime":"2025-12-19 22:35","pubTimestamp":1766154953,"startTime":"0","endTime":"0","summary":"截至2025年12月19日收盘，福安药业报收于4.7元，较前一交易日上涨0.86%，最新总市值为55.92亿元。该股当日开盘4.63元，最高4.71元，最低4.6元，成交额达1.82亿元，换手率为4.02%。公司近日发布公告，宣布将于2026年1月6日召开2026年第一次临时股东会，会议由公司董事会召集，现场会议时间为当日14:30，网络投票时间为同日9:15至15:00。股权登记日为2025年12月30日。股东可于2026年1月5日通过现场、传真或信函方式完成登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121900039675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300194","BK0060","BK0028","BK0239"],"gpt_icon":0},{"id":"2591451672","title":"福安药业：截止12月10日股东户数为38855户","url":"https://stock-news.laohu8.com/highlight/detail?id=2591451672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591451672?lang=zh_cn&edition=full","pubTime":"2025-12-16 11:37","pubTimestamp":1765856220,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业(300194)12月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年12月10日股东人数是多少？福安药业回复：截止12月10日，公司股东户数为38855户，谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600015373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0028","BK0060","300194"],"gpt_icon":0},{"id":"2590382715","title":"福安药业（300194）披露子公司收到药品注册证书，12月10日股价上涨1.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590382715","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590382715?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:15","pubTimestamp":1765376150,"startTime":"0","endTime":"0","summary":"截至2025年12月10日收盘，福安药业报收于4.56元，较前一交易日上涨1.56%，最新总市值为54.25亿元。该股当日开盘4.48元，最高4.59元，最低4.44元，成交额达9351.98万元，换手率为2.13%。公司于近日发布公告称，其全资子公司福安药业集团湖北人民制药有限公司近日收到国家药品监督管理局签发的注射用硫酸艾沙康唑药品注册证书，批准文号为国药准字H20256127，注册分类为化学药品4类，规格0.2g，适用于治疗成人侵袭性曲霉病和侵袭性毛霉病。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000041588.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300194","BK0028","BK0060"],"gpt_icon":0},{"id":"2589622338","title":"福安药业(300194.SZ)子公司产品纳入国家医保药品目录","url":"https://stock-news.laohu8.com/highlight/detail?id=2589622338","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589622338?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:11","pubTimestamp":1765181474,"startTime":"0","endTime":"0","summary":"智通财经APP讯，福安药业(300194.SZ)公告，据国家医保局、人力资源社会保障部发布《关于印发<国家基本医疗保险、生育保险和工伤保险药品目录>(2025年)的通知》，公司下属子公司产品帕拉米韦注射液被纳入《国家医保药品目录》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"福安药业(300194.SZ)子公司产品纳入国家医保药品目录","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300194","BK0060","BK0028","BK0132","BK0239"],"gpt_icon":0},{"id":"2588576080","title":"福安药业：多维度提升管理效能","url":"https://stock-news.laohu8.com/highlight/detail?id=2588576080","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588576080?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:31","pubTimestamp":1764660662,"startTime":"0","endTime":"0","summary":"证券之星消息，福安药业12月02日在投资者关系平台上答复投资者关心的问题。未来，公司将持续提高研发水平、努力开拓市场，多维度提升管理效能，积极推动公司的可持续发展和盈利能力提升。在努力为股东创造长期价值回报的基础上，公司将通过多渠道与投资者保持良好互动交流，积极向市场传递公司投资价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200017196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","BK0028","BK0060","300194"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771910047631,"stockEarnings":[{"period":"1week","weight":-0.0202},{"period":"1month","weight":-0.0563},{"period":"3month","weight":-0.0802},{"period":"6month","weight":-0.1062},{"period":"1year","weight":-0.0037},{"period":"ytd","weight":-0.0158}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"福安药业(集团)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"38647人(较上一季度减少1.04%)","perCapita":"25056股","listingDate":"2011-03-22","address":"重庆市长寿区化南一路1号","registeredCapital":"118971万元","survey":" 福安药业(集团)股份有限公司的主营业务是化学药品的研发、生产、销售。公司的主要产品是庆大霉素、头孢唑肟钠、头孢美唑钠、拉氧头孢钠、头孢他啶、枸橼酸托瑞米芬片（制剂）、盐酸昂丹司琼（原料药、制剂）、盐酸格拉司琼（原料药、制剂）、多索茶碱（原料药、制剂）、尼麦角林胶囊、舒林酸片、谷胱甘肽。","listedPrice":41.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福安药业,300194,福安药业股票,福安药业股票老虎,福安药业股票老虎国际,福安药业行情,福安药业股票行情,福安药业股价,福安药业股市,福安药业股票价格,福安药业股票交易,福安药业股票购买,福安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福安药业(300194)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福安药业(300194)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}